Publications by authors named "Monica Arnedos"

40Publications

Window of Opportunity trials for biomarker discovery in breast cancer.

Curr Opin Oncol 2019 11;31(6):486-492

IOB Institute of Oncology, Quiron, Madrid.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000583DOI Listing
November 2019

Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door.

Eur J Cancer 2018 03 3;92:1-10. Epub 2018 Feb 3.

Drug Development Department, Gustave Roussy, Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Kremlin-Bicêtre, France; Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.020DOI Listing
March 2018

Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patients.

Mol Oncol 2016 11 5;10(9):1430-1436. Epub 2016 Aug 5.

Departement de Biologie et Pathologie Médicales, Gustave Roussy Cancer Campus, Villejuif, France; Laboratoire de Recherche Translationnelle et Centre de Ressources Biologiques, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423214PMC
November 2016

Precision medicine for metastatic breast cancer--limitations and solutions.

Nat Rev Clin Oncol 2015 Dec 21;12(12):693-704. Epub 2015 Jul 21.

Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2015.123
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2015.123DOI Listing
December 2015

Targeted therapies for ER+/HER2- metastatic breast cancer.

BMC Med 2015 Jun 9;13:137. Epub 2015 Jun 9.

Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916
Publisher Site
http://dx.doi.org/10.1186/s12916-015-0369-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462184PMC
June 2015

Ki67--no evidence for its use in node-positive breast cancer.

Nat Rev Clin Oncol 2015 May 17;12(5):296-301. Epub 2015 Mar 17.

Department of Medical Oncology, Gustave Roussy Institute, 114 rue E. Vaillant, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.46DOI Listing
May 2015

Personalized treatments of cancer patients: a reality in daily practice, a costly dream or a shared vision of the future from the oncology community?

Cancer Treat Rev 2014 Dec 17;40(10):1192-8. Epub 2014 Jul 17.

Department of Medicine, Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2014.07.002DOI Listing
December 2014

Statistical methods applied to omics data: predicting response to neoadjuvant therapy in breast cancer.

Curr Opin Oncol 2014 Nov;26(6):576-83

aService biostatistique et épidémiologie, Gustave-Roussy, Villejuif, bUniversity Paris-Sud, Le Kremlin-Bicêtre cDépartement de médecine, Pathologie Mammaire, Gustave-Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000134DOI Listing
November 2014

Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.

Breast J 2014 Jul-Aug;20(4):381-7. Epub 2014 Jun 2.

Department of Radiotherapy, Institut Gustave Roussy, Paris XI University, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12277DOI Listing
July 2015

The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?

J Pathol 2014 Jan;232(2):274-82

Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France; Inserm Unit U981, Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4276DOI Listing
January 2014

Issues in clinical research for metastatic breast cancer.

Curr Opin Oncol 2013 Nov;25(6):625-9

aINSERM Unit U981, Université Paris Sud, Gustave Roussy bDepartment of Medical Oncology, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000018DOI Listing
November 2013

Quantification of residual risk of relapse in breast cancer patients optimally treated.

Breast 2013 Aug;22 Suppl 2:S92-5

INSERM Unit U981 and Breast Cancer Unit, Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.07.017DOI Listing
August 2013

Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives.

Cancer Discov 2013 Mar 15;3(3):264-79. Epub 2013 Feb 15.

Breast Cancer Unit, INSERM Unit U981, Gustave Roussy Institute, Villejuif, France.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-12-0362DOI Listing
March 2013

Landscape and evolution of therapeutic research for breast cancer patients.

Breast Cancer Res Treat 2013 Feb 14;138(1):319-24. Epub 2013 Feb 14.

INSERM Unit U981 and Université Paris Sud, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2436-yDOI Listing
February 2013

Triple-negative breast cancer: are we making headway at least?

Ther Adv Med Oncol 2012 Jul;4(4):195-210

Breast Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834012444711DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384094PMC
July 2012

Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients.

Breast Cancer Res Treat 2012 Jun 15;133(3):1191-8. Epub 2012 Mar 15.

Department of Medical Oncology, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2010-zDOI Listing
June 2012

Tumor genotyping for breast cancer: at the front door.

Per Med 2011 Jul;8(4):383-385

Department of Medical Oncology & INSERM U981, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme.11.42DOI Listing
July 2011

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.

Mod Pathol 2011 Feb 12;24(2):209-31. Epub 2010 Nov 12.

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.205DOI Listing
February 2011

Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancer.

Breast Cancer Res Treat 2008 Nov 1;112(1):1-4. Epub 2007 Dec 1.

Breast Unit, The Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-007-9826-y
Publisher Site
http://dx.doi.org/10.1007/s10549-007-9826-yDOI Listing
November 2008

Progression of endocrine therapies for breast cancer: where are we headed?

Expert Rev Anticancer Ther 2007 Nov;7(11):1651-64

The Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.7.11.1651DOI Listing
November 2007

Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC).

Breast Cancer Res Treat 2008 Aug 13;110(3):411-6. Epub 2007 Sep 13.

Institut Catala d'Oncologia, Hospital Duran i Reynalds, Gran Via km 2.7. L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-007-9745-y
Publisher Site
http://dx.doi.org/10.1007/s10549-007-9745-yDOI Listing
August 2008

The evolution of adjuvant endocrine therapy: developments since St Gallen 2005.

Breast 2007 Dec 30;16 Suppl 2:S4-9. Epub 2007 Aug 30.

Breast Unit, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2007.07.001DOI Listing
December 2007

Emerging targeted therapies for breast cancer.

Hematol Oncol Clin North Am 2007 Apr;21(2):321-40

Breast Unit, Department of Medicine, The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2007.03.005DOI Listing
April 2007